David Meyronet - Publications

Affiliations: 
Universite Lyon 1, Villeurbanne, Auvergne-Rhône-Alpes, France 
Area:
Semaphorin, CRMP, MAPK, Cancer, Marker, Cell migration, Apoptosis

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chefdeville A, Treilleux I, Mayeur ME, Couillault C, Picard G, Bost C, Mokhtari K, Vasiljevic A, Meyronet D, Rogemond V, Psimaras D, Dubois B, Honnorat J, Desestret V. Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis. Acta Neuropathologica Communications. 7: 38. PMID 30857565 DOI: 10.1186/s40478-019-0693-7  0.36
2018 Izquierdo C, Barritault M, Poncet D, Cartalat S, Joubert B, Bruna J, Jouanneau E, Guyotat J, Vasiljevic A, Fenouil T, Berthezène Y, Honnorat J, Meyronet D, Ducray F. Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations. Neurosurgery. PMID 30407589 DOI: 10.1093/neuros/nyy513  0.36
2018 Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J. Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies. Journal of Neurology. PMID 30003358 DOI: 10.1007/s00415-018-8970-0  0.36
2018 Bronnimann C, Izquierdo C, Cartalat S, Thomas L, Joubert B, Delpech L, Barritault M, Meyronet D, Honnorat J, Ducray F. Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy. Journal of Neuro-Oncology. PMID 29388033 DOI: 10.1007/s11060-018-2780-1  0.36
2017 Picart T, Barritault M, Berthillier J, Meyronet D, Vasiljevic A, Frappaz D, Honnorat J, Jouanneau E, Poncet D, Ducray F, Guyotat J. Characteristics of cerebellar glioblastomas in adults. Journal of Neuro-Oncology. PMID 29196927 DOI: 10.1007/s11060-017-2682-7  0.36
2017 Royet A, Broutier L, Coissieux MM, Malleval C, Gadot N, Maillet D, Gratadou-Hupon L, Bernet A, Nony P, Treilleux I, Honnorat J, Liebl D, Pelletier L, Berger F, Meyronet D, et al. Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4. Oncotarget. PMID 28424425 DOI: 10.18632/oncotarget.16077  0.36
2017 Royet A, Broutier L, Coissieux MM, Malleval C, Gadot N, Maillet D, Gratadou-Hupon L, Bernet A, Nony P, Treilleux I, Honnorat J, Liebl D, Pelletier L, Berger F, Meyronet D, et al. Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4. Oncotarget. 8: 23750-23759. PMID 28423606 DOI: 10.18632/oncotarget.16077  0.36
2017 Meyronet D, Esteban-Mader M, Bonnet C, Joly MO, Uro-Coste E, Amiel-Benouaich A, Forest F, Rousselot-Denis C, Burel-Vandenbos F, Bourg V, Guyotat J, Fenouil T, Jouvet A, Honnorat J, Ducray F. Characteristics of H3 K27M-mutant gliomas in adults. Neuro-Oncology. PMID 28201752 DOI: 10.1093/neuonc/now274  0.36
2016 Bonnin N, Armandy E, Carras J, Ferrandon S, Battiston-Montagne P, Aubry M, Guihard S, Meyronet D, Foy JP, Saintigny P, Ledrappier S, Jung A, Rimokh R, Rodriguez-Lafrasse C, Poncet D. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma. Oncotarget. PMID 27281619 DOI: 10.18632/oncotarget.9829  0.36
2016 Theillac M, Meyronet D, Savatovsky J, Makris N, Hannoun S, Grand S, Cotton F. Dynamic susceptibility contrast perfusion imaging in biopsy-proved adult medulloblastoma. Journal of Neuroradiology. Journal De Neuroradiologie. PMID 27262628 DOI: 10.1016/j.neurad.2016.05.002  0.36
2016 Marzolf G, Sabou M, Lannes B, Cotton F, Meyronet D, Galanaud D, Cottier JP, Grand S, Desal H, Kreutz J, Schenck M, Meyer N, Schneider F, Dietemann JL, Koob M, et al. Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations. Plos One. 11: e0152475. PMID 27097323 DOI: 10.1371/journal.pone.0152475  0.36
2016 Bonnet C, Thomas L, Psimaras D, Bielle F, Vauléon E, Loiseau H, Cartalat-Carel S, Meyronet D, Dehais C, Honnorat J, Sanson M, Ducray F. Characteristics of gliomas in patients with somatic IDH mosaicism. Acta Neuropathologica Communications. 4: 31. PMID 27036230 DOI: 10.1186/s40478-016-0302-y  0.36
2016 Ronsin S, Deiana G, Geraldo AF, Durand-Dubief F, Thomas-Maisonneuve L, Formaglio M, Desestret V, Meyronet D, Nighoghossian N, Berthezène Y, Honnorat J, Ducray F. Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation. Neurology. 86: 912-9. PMID 26850981 DOI: 10.1212/WNL.0000000000002444  0.36
2015 Laurencin C, André-Obadia N, Camdessanché JP, Mauguière F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, Ducray F, Honnorat J, Petiot P. Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome. Neurology. 85: 2076-8. PMID 26400578 DOI: 10.1212/WNL.0000000000002037  0.36
2015 Moutal A, Honnorat J, Massoma P, Désormeaux P, Bertrand C, Malleval C, Watrin C, Chounlamountri N, Mayeur ME, Besançon R, Naudet N, Magadoux L, Khanna R, Ducray F, Meyronet D, et al. CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. Cancer Research. 75: 3519-28. PMID 26122847 DOI: 10.1158/0008-5472.CAN-14-0631  0.36
2015 Viaccoz A, Ducray F, Tholance Y, Barcelos GK, Thomas-Maisonneuve L, Ghesquières H, Meyronet D, Quadrio I, Cartalat-Carel S, Louis-Tisserand G, Jouanneau E, Guyotat J, Honnorat J, Perret-Liaudet A. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma. Neuro-Oncology. 17: 1497-503. PMID 26014047 DOI: 10.1093/neuonc/nov092  0.36
2015 Meyronet D, Dorey A, Massoma P, Rey C, Alix E, Silva K, Perrin C, Quadrio I, Perret-Liaudet A, Streichenberger N, Thomasset N, Honnorat J, Arzberger T, Kretzschmar H. The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 975-91. PMID 25976431 DOI: 10.1007/s00702-015-1378-4  0.36
2015 Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, et al. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. Jama Neurology. 72: 267-75. PMID 25559883 DOI: 10.1001/jamaneurol.2014.4068  0.36
2015 Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, ... ... Meyronet D, et al. Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 957-72. PMID 25239189 DOI: 10.1007/s00702-014-1304-1  0.36
2014 Garin D, Virgone-Carlotta A, Gözel B, Oukhatar F, Perret P, Marti-Battle D, Touret M, Millet P, Dubois-Dauphin M, Meyronet D, Streichenberger N, Laferla FM, Demeunynck M, Chierici S, Sallanon MM, et al. COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse model. Journal of Neurochemistry. PMID 25258048 DOI: 10.1111/jnc.12951  0.36
2013 Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, ... ... Meyronet D, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathologica. 126: 917-29. PMID 24174164 DOI: 10.1007/s00401-013-1198-2  0.36
2013 Brot S, Malleval C, Benetollo C, Auger C, Meyronet D, Rogemond V, Honnorat J, Moradi-Améli M. Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation. Experimental Cell Research. 319: 588-99. PMID 23298946 DOI: 10.1016/j.yexcr.2012.12.011  0.36
2012 Azimi-Nezhad M, Lambert D, Ottone C, Perrin C, Chapel C, Gaillard G, Pfister M, Masson C, Tabone E, Betsou F, Meyronet D, Ungeheuer MN, Siest SV. Influence of pre-analytical variables on VEGF gene expression and circulating protein concentrations. Biopreservation and Biobanking. 10: 454-61. PMID 24845047 DOI: 10.1089/bio.2012.0016  0.36
2012 Guclu B, Sindou M, Meyronet D, Streichenberger N, Simon E, Mertens P. Anatomical study of the central myelin portion and transitional zone of the vestibulocochlear nerve. Acta Neurochirurgica. 154: 2277-83; discussion . PMID 22914910 DOI: 10.1007/s00701-012-1479-x  0.36
2012 Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 22: 21-35. PMID 22789536 DOI: 10.1016/j.ccr.2012.05.037  0.36
2012 Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, ... ... Meyronet D, et al. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Experimental Gerontology. 47: 825-33. PMID 22705312 DOI: 10.1016/j.exger.2012.06.001  0.36
2011 Guclu B, Sindou M, Meyronet D, Streichenberger N, Simon E, Mertens P. Cranial nerve vascular compression syndromes of the trigeminal, facial and vago-glossopharyngeal nerves: comparative anatomical study of the central myelin portion and transitional zone; correlations with incidences of corresponding hyperactive dysfunctional syndromes. Acta Neurochirurgica. 153: 2365-75. PMID 21947457 DOI: 10.1007/s00701-011-1168-1  0.36
2011 Giaccone G, Arzberger T, Alafuzoff I, Al-Sarraj S, Budka H, Duyckaerts C, Falkai P, Ferrer I, Ironside JW, Kovács GG, Meyronet D, Parchi P, Patsouris E, Revesz T, Riederer P, et al. New lexicon and criteria for the diagnosis of Alzheimer's disease. The Lancet. Neurology. 10: 298-9; author reply . PMID 21435593 DOI: 10.1016/S1474-4422(11)70055-2  0.36
2011 Kovacs GG, Seguin J, Quadrio I, Höftberger R, Kapás I, Streichenberger N, Biacabe AG, Meyronet D, Sciot R, Vandenberghe R, Majtenyi K, László L, Ströbel T, Budka H, Perret-Liaudet A. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathologica. 121: 39-57. PMID 20593190 DOI: 10.1007/s00401-010-0713-y  0.36
2010 Peyre M, Cartalat-Carel S, Meyronet D, Ricard D, Jouvet A, Pallud J, Mokhtari K, Guyotat J, Jouanneau E, Sunyach MP, Frappaz D, Honnorat J, Ducray F. Prolonged response without prolonged chemotherapy: A lesson from PCV chemotherapy in low-grade gliomas Neuro-Oncology. 12: 1078-1082. PMID 20488959 DOI: 10.1093/neuonc/noq055  0.36
2009 Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, ... ... Meyronet D, et al. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathologica. 117: 635-52. PMID 19330340 DOI: 10.1007/s00401-009-0523-2  0.36
2009 Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, Boluda S, Bugiani O, Duyckaerts C, Gelpi E, Gentleman S, Giaccone G, Graeber M, Hortobagyi T, Höftberger R, ... ... Meyronet D, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathologica. 117: 309-20. PMID 19184666 DOI: 10.1007/s00401-009-0485-4  0.36
2008 Meyronet D, Massoma P, Thivolet F, Chalabreysse L, Rogemond V, Schlama A, Honnorat J, Thomasset N. Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma. The American Journal of Surgical Pathology. 32: 1699-708. PMID 18769332 DOI: 10.1097/PAS.0b013e31817dc37c  0.36
2008 Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, ... ... Meyronet D, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathology (Zurich, Switzerland). 18: 484-96. PMID 18371174 DOI: 10.1111/j.1750-3639.2008.00147.x  0.36
2008 Bell JE, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Budka H, Dexter DT, Falkai P, Ferrer I, Gelpi E, Gentleman SM, Giaccone G, Huitinga I, Ironside JW, Klioueva N, ... ... Meyronet D, et al. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathologica. 115: 497-507. PMID 18365220 DOI: 10.1007/s00401-008-0360-8  0.36
2008 Alafuzoff I, Pikkarainen M, Arzberger T, Thal DR, Al-Sarraj S, Bell J, Bodi I, Budka H, Capetillo-Zarate E, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kavantzas N, King A, ... ... Meyronet D, et al. Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathologica. 115: 533-46. PMID 18343933 DOI: 10.1007/s00401-008-0358-2  0.36
2008 Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kamphorst W, King A, Korkolopoulou P, ... ... Meyronet D, et al. Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Journal of Neuropathology and Experimental Neurology. 67: 125-43. PMID 18219257 DOI: 10.1097/nen.0b013e3181633526  0.36
2006 Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Hauw JJ, Kamphorst W, ... ... Meyronet D, et al. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. Journal of Neuropathology and Experimental Neurology. 65: 740-57. PMID 16896308 DOI: 10.1097/01.jnen.0000229986.17548.27  0.36
Show low-probability matches.